Income Statement

ONCOLYTICS BIOTECH INC

ONCY

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Dec 31, 2025 2025 FY
Revenue	-
Cost of Revenue	-
Gross Profit	-
Operating Expenses	28.73
Research & Development	13.31
Selling, General & Administrative	15.41
Other Operating Expenses	-
Operating Income	-28.73
Non-Operating Income	-0.05
Interest Income	0.39
Interest Expense	-
Other Non-Op Income / Expense	0.05
Income Before Tax	-28.68
Income Tax Expense	0.08
Non-Controlling Interest	-
Net Income	-28.76

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted